Register for our free email digests:
Penelope MacRae
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Penelope MacRae
Sandoz Accuses United Therapeutics Of Blocking Generic Remodulin
A Sandoz lawsuit has accused United Therapeutics of trying to illegally block sales of the first US generic version of Remodulin.
MS Pharma Acquires Genepharm In Expansion Push
MS Pharma, a leading generics company in the Middle East, has announced an agreement to acquire Greece-based Genepharm as part of an expansion drive into Europe and farther afield.
Rescue Plan For Debt-Laden Panacea Sees Shares Soar
Distressed asset fund India Resurgence Fund, run by Bain Capital and the Ajay Piramal group, has announced a $144m bailout for financially ailing Panacea Biotec.
Dr Reddy’s Acquires Portfolio Of 42 ANDAs To Spur Growth In US
Dr Reddy’s is expanding its portfolio by acquiring 42 ANDAs in the US as it seeks to develop its North American and emerging market operations.
Russia’s Generium Announces First Biosimilar Of Soliris
Russia’s Generium has announced its launch of the first biosimilar version of Alexion’s blockbuster orphan-disease drug Soliris, one of the most expensive prescription medicines in the world.
India’s Intas Launches Trastuzumab At A 65% Discount
India’s Intas Pharmaceuticals will undercut domestic rivals by marketing its new biosimilar trastuzumab at a price 65% cheaper than the current market cost.